Search

NEWS & REPORTS

Investor Relations

Investor Relations News

, Investors

Evonik made a good start to 2018


• Adjusted EBITDA rises 14 percent to €679 million
• Sales increase 1 percent to €3.68 billion
• Full-year forecast confirmed

More
, Investors

Evonik invests in American skin technology start-up mySkin


• Evonik is driving digitalization in the cosmetic industry
• mySkin’s unique handheld device “OKU” measures a variety of skin properties and recommends care products
• Breakthrough in how consumers can measure and improve their skin

More
, Investors

Evonik to close its Kaba site in Hungary


Essen (Germany) / Kaba (Hungary). Evonik will stop its amino acid production at its Hungarian Kaba site by the end of April 2018. There Evonik Agroferm Zrt., a subsidiary of Evonik, currently employs about 120 people.

More
more
Contact & Service

Contacts in the Investor Relations Depart-ment

more

Disclaimer

more